OPKO Health’s (OPK) “Buy” Rating Reiterated at HC Wainwright
HC Wainwright restated their buy rating on shares of OPKO Health (NASDAQ:OPK – Free Report) in a report released on Tuesday, Benzinga reports. They currently have a $3.00 target price on the biotechnology company’s stock. A number of other equities research analysts have also issued reports on OPK. StockNews.com raised OPKO Health to a sell […]
More Stories
Horizon Bancorp (NASDAQ:HBNC) Reaches New 52-Week High After Dividend Announcement
Horizon Bancorp, Inc. (NASDAQ:HBNC – Get Free Report)’s share price reached a new 52-week high during trading on Wednesday following...
Applied Optoelectronics, Inc. (NASDAQ:AAOI) Given Consensus Rating of “Moderate Buy” by Analysts
Applied Optoelectronics, Inc. (NASDAQ:AAOI – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the four...
Endava (NYSE:DAVA) Updates FY 2025 Earnings Guidance
Endava (NYSE:DAVA – Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company...
MillerKnoll (NASDAQ:MLKN) Updates FY 2025 Earnings Guidance
MillerKnoll (NASDAQ:MLKN – Get Free Report) issued an update on its FY 2025 earnings guidance on Thursday morning. The company...
UMB Financial Co. (NASDAQ:UMBF) Given Average Rating of “Buy” by Brokerages
Shares of UMB Financial Co. (NASDAQ:UMBF – Get Free Report) have earned an average rating of “Buy” from the six...
Brokerages Set Air Transport Services Group, Inc. (NASDAQ:ATSG) Price Target at $21.67
Air Transport Services Group, Inc. (NASDAQ:ATSG – Get Free Report) has received an average rating of “Moderate Buy” from the...